4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001395064-25-000172
10% owner acquired 1,250,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2025-12-08 | Conversion | +1,250,000 | 7,000,000 | I | ||
| Derivatives | |||||||
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2025-12-08 | Conversion · Series A Convertible Preferred Stock | −1,250 | 0 | I | ||
Loading xslF345X05/wk-form4_1765333162.xml…